Inventor · disambiguated record
David Fry
Also filed as: FRY DAVID · FRY DAVID A · FRY DAVID W · FRY DAVID WILLIAM
15 granted patents·4 pending applications·3,217 citations·filing 1990–2012
96Inventor score
Top patents by PatentIndex Score
19 records- 0198US6713484B2Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor familyWARNER LAMBERT CO·Filed 2002·Granted Mar 30, 2004·291 cites·8 claims
- 0298US6602863B1Irreversible inhibitors of tyrosine kinasesWARNER LAMBERT CO·Filed 2000·Granted Aug 5, 2003·236 cites·23 claims
- 0398US6521620B1Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor familyWARNER LAMBERT CO·Filed 1998·Granted Feb 18, 2003·295 cites·8 claims
- 0498US6455534B2Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor familyWARNER LAMBERT CO·Filed 2001·Granted Sep 24, 2002·274 cites·18 claims
- 0598US6344459B1Irreversible inhibitors of tyrosine kinasesWARNER LAMBERT CO·Filed 1997·Granted Feb 5, 2002·367 cites·17 claims
- 0698US5654307ABicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor familyWARNER LAMBERT CO·Filed 1994·Granted Aug 5, 1997·479 cites·2 claims
- 0797US6265410B1Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor familyWARNER LAMBERT CO·Filed 1998·Granted Jul 24, 2001·306 cites·45 claims
- 0897US6084095ASubstituted pyrido[3,2-d]pyrimidines capable of inhibiting tyrosine kinases of the epidermal growth factor receptor familyWARNER LAMBERT CO·Filed 1997·Granted Jul 4, 2000·292 cites·2 claims
- 0997US5679683ATricyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor familyWARNER LAMBERT CO·Filed 1994·Granted Oct 21, 1997·306 cites·2 claims
- 1096US6596726B1Tricyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor familyWARNER LAMBERT CO·Filed 1997·Granted Jul 22, 2003·232 cites·10 claims
- 1195US6498163B1Pyrido[2,3-D]pyrimidines and 4-aminopyrimidines as inhibitors of cellular proliferationWARNER LAMBERT CO·Filed 1998·Granted Dec 24, 2002·125 cites·44 claims
- 1275US7786131B2Pyrimido[5,4-d]pyrimidines derivatives as irreversible inhibitors of tyrosine kinasesWARNER LAMBERT CO·Filed 2003·Granted Aug 31, 2010·6 cites·8 claims
- 1346US2006293323A1Therapeutic Combinations of erb B Kinase Inhibitors and Antineoplastic TherapiesELLIOTT WILLIAM L·Filed 2006·Application pending·0 cites
- 1445US2004067942A1Therapeutic combinations of erb B kinase inhibitors and antineoplastic therapiesFiled 2003·Application pending·0 cites
- 1540US2005222163A1Combinations of signal transduction inhibitorsPFIZER·Filed 2005·Application pending·0 cites
- 1638US9234245B2Prognostic signature for colorectal cancer recurrenceWORZEL WILLIAM P·Filed 2012·Granted Jan 12, 2016·0 cites·4 claims
- 1736US5115207AAutomatic signal parameter controlSTC PLC·Filed 1990·Granted May 19, 1992·5 cites·9 claims
- 1836US2006190582A1Maintaining building serviceability information for geographic locationsFRY DAVID A·Filed 2005·Application pending·0 cites
- 1932US5721266ASubstituted imidazolinyl-imidazolines as antagonists of SH-2 binding and therapeutic uses thereofWARNER LAMBERT CO·Filed 1994·Granted Feb 24, 1998·3 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when David Fry files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →